[1] Fiegel HC,Kaufmann PM,Bruns H,et al.Hepatic tissue engineering:From transplantation to customized cell-based liver directed therapies from the laboratory.J Cell Mol Med. 2008;12(1):56-66.
[2] Lee SY,Kim HJ,Choi D.Cell sources, liver support systems and liver tissue engineering: alternatives to liver transplantation. Int J Stem Cells.2015; 8(1):36-47.
[3] Ohashi K,Yokoyama T,Yamato M,et al.Engineering functional two- and three-dimensional liver systems in vivo using hepatic tissue sheets.Nat Med. 2007;13(7):880-885.
[4] Kaufmann PM,Kneser U,Fiegel HC,et al.Is there an optimal concentration of cotransplanted islets of Langerhans for stimulation of hepatocytes in three dimensional matrices? Transplantation.1999;68:272-279.
[5] Ohashi K,Waugh JM,Dake MD,et al.Liver tissue engineering at extrahepatic sites in mice as a potential new therapy for genetic liver diseases.Hepatology.2005;41: 132-140.
[6] Yokoyamaa T,Ohashia K,Kugea H,et al.In vivo engineering of metabolically active hepatic tissues in a neovascularized subcutaneous cavity.Am J Transplant.2006; 6: 50-59.
[7] Shimizu T,Sekine H,Yang J,et al.Polysurgery of cell sheet grafts overcomes diffusion limits to produce thick, vascularized myocardial tissues.FASEB J.2006;20:708-710.
[8] Yap KK,Dingle AM,Palmer JA,et al.Enhanced liver progenitor cell survival and differentiation in vivo by spheroid implantation in a vascularized tissue engineering chamber. Biomaterials.2013;34(16):3992-4001.
[9] Zimmermann WH,Melnychenko I,Wasmeier G,et al. Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts.Nat Med.2006;12(4): 452-458.
[10] 赵云山,徐迎新,张博峰,等.以胶原凝胶为支架构建可植入工程化肝组织的实验研究[J].中华医学杂志,2007,87(29):2065-2068
[11] Reif R,Karlsson J,Günther G,et al.Bile canalicular dynamics in hepatocyte sandwich cultures.Arch Toxicol.2015.[Epub ahead of print]
[12] Cohen M,Levy G,Nahmias Y.Coculture and Long-Term Maintenance of Hepatocytes. Methods Mol Biol.2015;1250: 161-173.
[13] Borlak J,Singh PK,Rittelmeyer I.Regulation of Liver Enriched Transcription Factors in Rat Hepatocytes Cultures on Collagen and EHS Sarcoma Matrices. PLoS One.2015;10(4): e0124867.
[14] 赵云山,王常勇,郭希民,等.以液态胶原为支架构建组织工程化心肌组织的实验研究[J].中华医学杂志,2004,84(9):766-770.
[15] Tocchio A,Tamplenizza M,Martello F,et al.Versatile fabrication of vascularizable scaffolds for large tissue engineering in bioreactor.Biomaterials. 2015;45:124-131.
[16] Sakai Y,Yamanouchi K,Ohashi K,et al.Vascularized subcutaneous human liver tissue from engineered hepatocyte/fibroblast sheets in mice.Biomaterials.2015;65: 66-75.
[17] Wray LS,Tsioris K,Gi ES,et al.Slowly degradable porous silk microfabricated scaffolds for vascularized tissue formation. Adv Funct Mater.2013; 23(27):3404-3412.
[18] Enomoto Y,Enomura M,Takebe T,et al.Self-formation of vascularized hepatic tissue from human adult hepatocyte. Transplant Proc.2014;46(4):1243-1246.
[19] LaMattina JC,Kelly PJ,Hanish SI,et al.Intraoperative continuous veno-venous hemofiltration facilitates surgery in liver transplant patients with Acute renal failure.Transplant Proc.2015;47(6):1901-1904.
[20] Lindvig KP,Teisner AS,Kjeldsen J,et al.Allocation of patients with liver cirrhosis and organ failure to intensive care: Systematic review and a proposal for clinical practice.World J Gastroenterol.2015;21(29):8964-8973.
[21] Ding W,Xin J,Jiang L,et al.Characterisation of peripheral blood mononuclear cell microRNA in hepatitis B-related acute-on-chronic liver failure.Sci Rep.2015; 5:13098.
[22] Kim HY,Chang Y,Park JY,et al.Characterization of acute-on-chronic liver failure and prediction of mortality in Asian patients with active alcoholism. J Gastroenterol Hepatol. 2015.[Epub ahead of print]
[23] Hoekstra R,van Wenum M,Chamuleau RA.Pivotal preclinical trial of the spheroid reservoir bioartificial liver.J Hepatol.2015. [Epub ahead of print]
[24] You S,Zhu B,Liu H,et al.Safety of human hepatoma cell-line constructing bioartificial liver supporting system treating patients with liver failure. Hepatogastroenterology.2014; 61(132):933-936.
[25] Liu XY,Peng F,Pan YJ,et al.Advanced therapeutic strategies for HBV-related acute-on-chronic liver failure.Hepatobiliary Pancreat Dis Int. 2015;14(4):354-360.
[26] Hoshiba T,Otaki T,Nemoto E,et al.Blood-compatible polymer for hepatocyte culture with high hepatocyte-specific functions toward bioartificial liver development. ACS Appl Mater Interfaces. 2015;7(32):18096-18103.
[27] Yu B,He ZY,You P,et al.Reprogramming fibroblasts into bipotential hepatic stem cells by defined factors.Cell Stem Cell.2013;13(3):328-340.
[28] Schwartz RE,Fleming HE,Khetani SR,et al.Pluripotent stem cell-derived hepatocyte-like cells.Biotechnol Adv.2014;32(2): 504-513.
[29] Ordovás L,Park Y,Verfaillie CM.Stem cells and liver engineering.Biotechnol Adv. 2013;31(7):1094-1107.
Liu J,Brzeszczynska J,Samuel K,et al.Efficient episomal reprogramming of blood mononuclear cells and differentiation to hepatocytes with functional drug metabolism.Exp Cell Res. 2015.[Epub ahead of print] |